264 related articles for article (PubMed ID: 16085334)
1. Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: a new target to treat portal hypertension?
Sansoè G; Aragno M; Mastrocola R; Restivo F; Mengozzi G; Smedile A; Rosina F; Danni O; Parola M; Rizzetto M
J Hepatol; 2005 Nov; 43(5):791-8. PubMed ID: 16085334
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of kidney neutral endopeptidase (EC 3.4.24.11) and renal function in experimental cirrhosis.
Sansoè G; Aragno M; Mastrocola R; Cutrin JC; Silvano S; Mengozzi G; Smedile A; Rosina F; Danni O; Rizzetto M
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1337-43. PubMed ID: 16449355
[TBL] [Abstract][Full Text] [Related]
3. Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats.
Matei V; Rodríguez-Vilarrupla A; Deulofeu R; García-Calderó H; Fernández M; Bosch J; Garcia-Pagán JC
J Hepatol; 2008 Aug; 49(2):192-7. PubMed ID: 18534709
[TBL] [Abstract][Full Text] [Related]
4. Calcium receptors located in fibrotic septa: a new target to reduce portal pressure in liver cirrhosis.
Sansoè G; Aragno M; Mastrocola R; Paternostro C; Parola M
Clin Sci (Lond); 2013 Jul; 125(2):67-75. PubMed ID: 23384153
[TBL] [Abstract][Full Text] [Related]
5. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
Laviña B; Gracia-Sancho J; Rodríguez-Vilarrupla A; Chu Y; Heistad DD; Bosch J; García-Pagán JC
Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
[TBL] [Abstract][Full Text] [Related]
6. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
[TBL] [Abstract][Full Text] [Related]
7. Modulation of ANP-dependent effects of endothelin by inhibitors of neutral endopeptidase and cGMP phosphodiesterase.
Valentin JP; Qiu C; Wiedemann E; Gardner DG; Humphreys MH
J Pharmacol Exp Ther; 1995 May; 273(2):744-52. PubMed ID: 7752077
[TBL] [Abstract][Full Text] [Related]
8. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
García-Calderó H; Rodríguez-Vilarrupla A; Gracia-Sancho J; Diví M; Laviña B; Bosch J; García-Pagán JC
J Hepatol; 2011 Apr; 54(4):660-5. PubMed ID: 21159403
[TBL] [Abstract][Full Text] [Related]
9. The role of hepatic arterial flow on portal venous and hepatic venous wedged pressure in the isolated perfused CCl4-cirrhotic liver.
Zipprich A; Loureiro-Silva MR; D'Silva I; Groszmann RJ
Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G197-G202. PubMed ID: 18497333
[TBL] [Abstract][Full Text] [Related]
10. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
[TBL] [Abstract][Full Text] [Related]
11. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis.
Mizumoto M; Arii S; Furutani M; Nakamura T; Ishigami S; Monden K; Ishiguro S; Fujita S; Imamura M
J Surg Res; 1997 Jul; 70(2):124-33. PubMed ID: 9245560
[TBL] [Abstract][Full Text] [Related]
12. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance.
Rockey DC; Weisiger RA
Hepatology; 1996 Jul; 24(1):233-40. PubMed ID: 8707268
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic peptide, arginine vasopressin, aldosterone and plasma renin activity in carbon tetrachloride-induced cirrhosis in rats.
Elias AN; Vaziri ND; Domurat ES; Pandian MR; Ansari MA; Yazdani M
J Pharmacol Exp Ther; 1990 Jan; 252(1):438-41. PubMed ID: 2137178
[TBL] [Abstract][Full Text] [Related]
14. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
[TBL] [Abstract][Full Text] [Related]
15. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension.
Oberti F; Sogni P; Cailmail S; Moreau R; Pipy B; Lebrec D
Hepatology; 1993 Sep; 18(3):621-7. PubMed ID: 8359803
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats.
Abraldes JG; Rodríguez-Vilarrupla A; Graupera M; Zafra C; García-Calderó H; García-Pagán JC; Bosch J
J Hepatol; 2007 Jun; 46(6):1040-6. PubMed ID: 17335931
[TBL] [Abstract][Full Text] [Related]
17. Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance.
Zhang ZQ; Qiu JF; Luo M; Sun YW; Zhao G; Chen W; Liu H; Wu ZY
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e487-93. PubMed ID: 18070013
[TBL] [Abstract][Full Text] [Related]
18. Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model.
Sakamoto M; Nakamura T; Torimura T; Iwamoto H; Masuda H; Koga H; Abe M; Hashimoto O; Ueno T; Sata M
J Gastroenterol Hepatol; 2013 Jan; 28(1):168-78. PubMed ID: 22849788
[TBL] [Abstract][Full Text] [Related]
19. Hormonal, renal, hemodynamic responses to acute neutral endopeptidase inhibition in heart transplant patients.
Piquard F; Richard R; Charloux A; Doutreleau S; Hannedouche T; Brandenberger G; Geny B
J Appl Physiol (1985); 2002 Aug; 93(2):569-75. PubMed ID: 12133866
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.
Schaffner D; Lazaro A; Deibert P; Hasselblatt P; Stoll P; Fauth L; Baumstark MW; Merfort I; Schmitt-Graeff A; Kreisel W
World J Gastroenterol; 2018 Oct; 24(38):4356-4368. PubMed ID: 30344420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
